Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Meta Platforms' Core Growth, Muse Opportunity Support Further Upside, Morgan Stanley Says

Meta Platforms' Core Growth, Muse Opportunity Support Further Upside, Morgan Stanley Says

MT newswireMT newswire2026/10/22 15:00
11:00 AM EDT, 10/22/2026 (MT Newswires) -- Meta Platforms' (META) core business continues to show a "long" growth runway, while emerging artificial intelligence products such as Muse offer additional opportunities that are not priced in shares, Morgan Stanley said in a note Thursday. The investment bank said Meta's core business continues to impress, with double-digit growth in time spent on Facebook and Instagram, improving advertising conversion and lower content processing costs after the company moved content understanding models to its Muse model family. Muse remains an early agentic leader, Morgan Stanley said, noting that more than 10 million users created personal agents during the first six weeks in the US and Canada, with about 25% using Muse daily. Shopping has emerged as the leading use case, supporting the firm's view of longer-term monetization potential, according to the note. Calling Meta the "cleanest consumer GenAI winner," the investment bank said Meta has multiple call options not priced in shares, including Muse, subscriptions, business agents, and enterprise and API offerings. Morgan Stanley maintained an overweight rating on Meta Platforms, with a price target of $820. Price: 652.58, Change: -44.94, Percent Change: -6.44
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Survival period doubled! AstraZeneca's new stomach cancer drug Sone-ve aims for $5 billion in annual sales, ADC takes another step towards replacing chemotherapy

AstraZeneca's gastric cancer ADC doubles patient survival, extending life by five more months, aiming for annual sales of $5 billion; the company is racing with Takeda and Astellas to target Claudin 18.2.

智通财经•2026/10/26 01:36

16 trillion Korean won "big dividend"! SK hynix (SKHY.US) plans to distribute 80% of Kioxia stake earnings generously to shareholders

According to reports, SK Hynix plans to return about 80% of the proceeds from reducing its stake in Japan's Kioxia Holdings to shareholders by distributing a special dividend of approximately 16 trillion won (about $12 billion).

智通财经•2026/10/26 01:22

Korean retail investors start bottom fishing! Their targets are still "Samsung and SK Hynix leveraged ETFs"

Amid a sharp drop in Korean stocks, Korean retail investors turned contrarian, making a net purchase of over 315.4 billion KRW in leveraged products of Samsung and SK Hynix in October alone. They simultaneously spent 4.7 trillion KRW acquiring US-listed triple-leveraged semiconductor ETF (SOXL), accounting for nearly 74% of total purchases of US stocks during the same period. This marks the first rebound since tightening regulations in July and two consecutive months of net selling.

华尔街见闻•2026/10/26 00:41
Korean retail investors start bottom fishing! Their targets are still "Samsung and SK Hynix leveraged ETFs"

AI Bubble Index at 74, CoreWeave (CRWV.US) stock price may fall below $50

CoreWeave's stock price has dropped nearly 70% from its peak to $54.25, with the short interest ratio rising to 15%. As the AI bubble index reaches an extreme value of 74 and the company faces $3 billion in debt pressure, its share price is at risk of falling below the critical support level of $50.

智通财经•2026/10/26 00:36
AI Bubble Index at 74, CoreWeave (CRWV.US) stock price may fall below $50